๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2817969 69 M MA 12/26/2024 COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 LM7786
LM776
LM776
Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood ... Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Rhabdomyolysis; Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Blood creatinine normal, Musculoskeletal stiffness; Myalgia More
Rhabdomyolysis while hiking. Increased CK Increased LFT. Tx: Rest, hydration. Resolved. Rhabdomyolysis while hiking. Increased CK Increased LFT. Tx: Rest, hydration. Resolved.
2829016 31 F PA 03/02/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA





Back pain, Blood test, Hyperhidrosis, Hypoaesthesia, Hypotonia; Loss of consciou... Back pain, Blood test, Hyperhidrosis, Hypoaesthesia, Hypotonia; Loss of consciousness, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal, Myelitis transverse, Paralysis; Scan with contrast, Sleep disorder, Thirst; Back pain, Blood test, Hyperhidrosis, Hypoaesthesia, Hypotonia; Loss of consciousness, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal, Myelitis transverse, Paralysis; Scan with contrast, Sleep disorder, Thirst More
10 days after first dose I ended up waking up in the middle of the night extremely sweaty and thirst... 10 days after first dose I ended up waking up in the middle of the night extremely sweaty and thirsty, when i went to the kitchen, I went limp on the floor in a paralyzed state as if I had a mini stroke covered in sweat and unable to move for several minutes. Once i came to i was able to crawl to my husband who rushed me to hospital ER. December 2023- MRI shows signs ICP. March 2024- woke up and have lost feeling in lower limbs bilaterally. Sent to ER. After follow up with Neuro and many test, diagnosed with Transverse Myelitis. New studies linking Covid vaccine to TM, ICP, mini strokes. More
โœ“
2828914 03/01/2025 HPV9
 MERCK & CO. INC.
 W031448
Expired product administered, No adverse event Expired product administered, No adverse event
No additional adverse event; An office manager called to report an AE where a dose of GARDASIL 9 was... No additional adverse event; An office manager called to report an AE where a dose of GARDASIL 9 was administered to a patient after it's expiration date. No additional information provided to further clarify the details. No additional adverse effects reported. No additional AE; This spontaneous report was received from a consumer and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and previous drugs reactions or allergies were not reported. On 25-FEB-2025, the patient was vaccinated with an expired dose of human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) administered as prophylaxis (Lot No. W031448 has been verified to be a valid lot number for [human papillomavirus 9-valent vaccine, recombinant suspension for injection], expiration date reported and upon internal validation established as 12-FEB-2025) (strength, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided) (expired product administered). No additional adverse event was reported (no adverse event). More
2828915 FL 03/01/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Herpes zoster, Pain, Pruritus, Vaccination failure Herpes zoster, Pain, Pruritus, Vaccination failure
Suspected vaccination failure; Shingles; This serious case was reported by a consumer via call cente... Suspected vaccination failure; Shingles; This serious case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis. In OCT-2024, the patient received Shingrix. In DEC-2024, less than 2 months after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix. The company considered the vaccination failure and shingles to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 19-FEB-2025 The patient had been dealing with shingles since middle of December 2024 and still had unbelievable itching ,pain constantly. The patient had tried everything and nothing has helped. The patient asked for suggestions that can help and this was after the vaccine in October. The patient was wondering how this help seemed not to have helped. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix. Herpes zoster is an unlisted event which is considered unrelated to GSK vaccine Shingrix. More
2828916 03/01/2025 RVX
 UNKNOWN MANUFACTURER
 UNK
Cough, Fatigue, Respiratory syncytial virus infection, Vaccination failure Cough, Fatigue, Respiratory syncytial virus infection, Vaccination failure
Respiratory syncytial virus infection; Suspected vaccination failure; This serious case was reported... Respiratory syncytial virus infection; Suspected vaccination failure; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 84-year-old patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and respiratory syncytial virus infection (Verbatim: Respiratory syncytial virus infection) (serious criteria hospitalization and GSK medically significant). The outcome of the vaccination failure and respiratory syncytial virus infection were not reported. It was unknown if the reporter considered the vaccination failure and respiratory syncytial virus infection to be related to RSV vaccine. The company considered the vaccination failure and respiratory syncytial virus infection to be unrelated to RSV vaccine. Additional Information: GSK Receipt Date: 20-FEB-2025 This case was reported by a patient via interactive digital media. The patient had the RSV vaccine and a few months later was in the hospital with the RSV infection. The patient was 84 years old, and it was horrible. After going home 8 days later stayed in room for a month, exhausted and coughing all time. The patient would definitely get the shot. This case was considered as suspected vaccination failure as details regarding laboratory confirmation regarding respiratory syncytial virus infection were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding time to onset and laboratory confirmation of disease) is considered unrelated to GSK RSV vaccine. Respiratory syncytial virus infection is an unlisted event which is considered unrelated to GSK RSV vaccine. More
โœ“
2828917 KY 03/01/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
Death Death
The two people that died from an RSV vaccine; This serious case was reported by a physician via call... The two people that died from an RSV vaccine; This serious case was reported by a physician via call center representative and described the occurrence of unknown cause of death in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced unknown cause of death (Verbatim: The two people that died from an RSV vaccine) (serious criteria death and GSK medically significant). The reported cause of death was unknown. It was unknown if the reporter considered the unknown cause of death to be related to Arexvy. The company considered the unknown cause of death to be unrelated to Arexvy. Additional Information: GSK Receipt Date: 26-FEB-2025 The reporter reported that two people that have died from an RSV vaccine. The reporter would like to receive data on the circumstances surrounding their deaths. No further details provided.; Sender's Comments: Death is an unlisted event which is considered unrelated to GSK vaccine Arexvy.; Reported Cause(s) of Death: Unknown cause of death More
โœ“
2828924 61 M TX 03/01/2025 COVID19
 PFIZER\BIONTECH
 Lp1780
Chills Chills
Severe chills Severe chills
2828925 59 F TN 03/01/2025 COVID19
COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
MODERNA
 052E21A
052E21A
039D21A
039D21A
Antiphospholipid syndrome, Blood test abnormal, Dizziness, Feeling abnormal, Hyp... Antiphospholipid syndrome, Blood test abnormal, Dizziness, Feeling abnormal, Hypoaesthesia; Palpitations, Skin discolouration, Thrombosis; Antiphospholipid syndrome, Blood test abnormal, Dizziness, Feeling abnormal, Hypoaesthesia; Palpitations, Skin discolouration, Thrombosis More
Patient was feeling dizzy and heart felt like it was racing within 12 hours of being administered. ... Patient was feeling dizzy and heart felt like it was racing within 12 hours of being administered. Heart normalized but the dizziness continued. Patient kept feeling bad and on 10/25/2021 she went to the doctor. At the beginning of the year her fingers began feeling numb and turning color until eventually they were a purple color. Patient was misdiagnosed to have Raynaud's but then later it was discovered that she had a blood clot in her arm restricting blood flow to her fingers. After issue with the clot was resolved she was referred to a Hematologist for testing and was diagnosed with Antiphospholipid syndrome. More
โœ“ โœ“ โœ“
2828926 35 F MI 03/01/2025 COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 EL9265
EL9265
EL9265
Arthralgia, Blood test, Headache, Joint stiffness, Mast cell activation syndrome... Arthralgia, Blood test, Headache, Joint stiffness, Mast cell activation syndrome; Muscular weakness, Nausea, Pain, Pyrexia, Undifferentiated connective tissue disease; Urine analysis, Whole body scan More
Bodyaches, headache, fever, joint stiffness and pain, muscle weakness, nausea. Vaccine resulted in ... Bodyaches, headache, fever, joint stiffness and pain, muscle weakness, nausea. Vaccine resulted in UCTD and MCAS. More
โœ“
2828927 37 M IA 03/01/2025 COVID19
COVID19
 MODERNA
MODERNA

Blood test normal, Computerised tomogram, Electrocardiogram ambulatory, Electroc... Blood test normal, Computerised tomogram, Electrocardiogram ambulatory, Electrocardiogram normal, Palpitations; Scan myocardial perfusion, X-ray More
Since I have gotten the shot my palpations have gotten worse I would only get them on occasion now w... Since I have gotten the shot my palpations have gotten worse I would only get them on occasion now when I get them they last for days or weeks with no end nothing makes them calm down and I have ended up in the er many times due to this ongoing issue where I have had them now for a month and have to get a halter monitor put on More
2828928 11 M PA 03/01/2025 MNQ
MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
 9M2R7
9M2R7
Erythema, Headache, Induration, Pruritus, Skin warm; Tenderness Erythema, Headache, Induration, Pruritus, Skin warm; Tenderness
Arm became red, hard, warm to the touch, tender, and itchy. Patient also c/o mild headache. Arm became red, hard, warm to the touch, tender, and itchy. Patient also c/o mild headache.
2828929 78 F FL 03/01/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 7ZM55
Dizziness, Loss of consciousness, Syncope Dizziness, Loss of consciousness, Syncope
Patient fainted the morning after receiving the SHINGRIX shot. She reported feeling lightheaded and ... Patient fainted the morning after receiving the SHINGRIX shot. She reported feeling lightheaded and dizzy shortly before fainting, but mentioned she had a full breakfast and wasn't dehydrated in any way. Luckily, someone had caught her before she had passed out on the ground. She received medical attention promptly from an ambulance. More
2828930 72 F GA 03/01/2025 PNC21
 MERCK & CO. INC.
 Y013009
Erythema, Pain in extremity, Rash, Urticaria Erythema, Pain in extremity, Rash, Urticaria
Patient came to the pharmacy and showed the spot on her arm, it was red, and the skin was raised ind... Patient came to the pharmacy and showed the spot on her arm, it was red, and the skin was raised indicative or hives. Patient reported soreness in the arm still 2 days after vaccine. Patient was able to raise her arm and move it without discomfort other then general soreness. The rash itself was still painful to the touch. Instructed patient to take Benadryl to help with the histamine response, and to contact provider asap. Also instructed patient to monitor the site to make sure it doesn't get any bigger. If it continues expanding or any signs of anaphylaxis to seek immediate medical attention More
2828931 80 M 03/01/2025 PNC20
 PFIZER\WYETH
 lg5579
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient received a second prevnar 20 shot. one in 2022 and one now in 2025. no adverse events were r... Patient received a second prevnar 20 shot. one in 2022 and one now in 2025. no adverse events were reported at this time More
2828932 77 F AL 03/01/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 93kk4
Rash, Swelling, Viral infection Rash, Swelling, Viral infection
Patient states she had swelling, and a viral episode breakout of the mouth that started 48 hours af... Patient states she had swelling, and a viral episode breakout of the mouth that started 48 hours after vaccine More
2828933 62 F TX 03/01/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Oral herpes, Ulcerative keratitis Oral herpes, Ulcerative keratitis
Sunday, february 16 I had Multiple fever blisters on bottom lip. Worst outbreak I ever had in 60 yea... Sunday, february 16 I had Multiple fever blisters on bottom lip. Worst outbreak I ever had in 60 years. Saturday, March 1st I had corneal ulcer diagnosed by doctor. More
2828934 66 F FL 03/01/2025 COVID19
FLU3
 PFIZER\BIONTECH
SANOFI PASTEUR
 LM2216
UT8463DA
Injection site pain, Musculoskeletal chest pain, Pain, Periarthritis; Injection ... Injection site pain, Musculoskeletal chest pain, Pain, Periarthritis; Injection site pain, Musculoskeletal chest pain, Pain, Periarthritis More
Evening after vaccine, left arm was extremely painful at injection site. Following week I experience... Evening after vaccine, left arm was extremely painful at injection site. Following week I experienced sharp jabbing intermittent pain at left ribcage. Following weeks left arm a shoulder became extremely painful when trying to move frozen arm. Saw Dr 2 months after vaccines due to extremely painful and frozen shoulder. Dr diagnosed adhesive capsulitis. I was prescribed steroid pack, which I am taking for 6 days. Physical therapy was prescribed also, along with follow up if there are no improvements. More
2828935 76 F FL 03/01/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 255T2
Extra dose administered Extra dose administered
1st dose was given 9/25/2023 and then a 2nd dose was given 2/28/2025 (not recommended by cdc) 1st dose was given 9/25/2023 and then a 2nd dose was given 2/28/2025 (not recommended by cdc)
2828936 57 F VA 03/01/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Chills, Fatigue, Headache, Influenza like illness, Pain; Pyrexia Chills, Fatigue, Headache, Influenza like illness, Pain; Pyrexia
Severe flu-like symptoms including high fever, chills, aches, fatigue, headache Severe flu-like symptoms including high fever, chills, aches, fatigue, headache
2828937 56 F PR 03/01/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 27LR2
Injection site erythema, Injection site inflammation, Injection site warmth Injection site erythema, Injection site inflammation, Injection site warmth
PATIENT STATED PRESENTED RED AREAS AROUND ADMINISTRATION AREA THAT LOOKED LIKE A MAP THEY WERE DISPE... PATIENT STATED PRESENTED RED AREAS AROUND ADMINISTRATION AREA THAT LOOKED LIKE A MAP THEY WERE DISPERSE AROUND ADMINISTRATION AREA SHE REPORTED INFLAMATION ON AREA AND FEELING OF WARM ON THE SKIN. NO RASH OR ITCH OR FEVER OR OTHER SYMPTOM REPORTED . PATIENT STATED SHE USED COLD COMPRESSES ON AREA AND SYMPTOMS IMPROVE WITHIN DAYS AND SINCE SHE ALSO TAKES MELOXICAM INFLAMMATION IMPROVED . PATIENT WAS ORIENTED TO TALK TO PRIMARY CARE PHYSICIAN SINCE SHE IS WORRIED ABOUT ADMINISTERING THE VACCINE SECOND DOSE More
2828938 57 F AL 03/01/2025 UNK
 UNKNOWN MANUFACTURER
 93et2
Dizziness, Nausea, Pain in extremity Dizziness, Nausea, Pain in extremity
patient said: dizzy, light headed, nausea and sore arm patient said: dizzy, light headed, nausea and sore arm
2828939 0.25 M TX 03/01/2025 RV5
RV5
RV5
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.


Abdominal rigidity, Blood test, Computerised tomogram abdomen, Dehydration, Diar... Abdominal rigidity, Blood test, Computerised tomogram abdomen, Dehydration, Diarrhoea; Emotional distress, Food allergy, Gastrointestinal pathogen panel, Gastrointestinal sounds abnormal, Haematochezia; Intussusception, Pyrexia, Rotavirus test positive, Ultrasound scan, Vomiting More
3/14 -3/15became dehydrated vomiting and diarrhea (hospital visit) tested positive for rotavirus 3... 3/14 -3/15became dehydrated vomiting and diarrhea (hospital visit) tested positive for rotavirus 3/29 admitted to hospital for continued symptoms and suspected Intussusception, hospital notes to back that up and noted his symptoms as guarding, inconsolable and fever also blood in stools discharged at the end of the day 3/30/2022 IV fluids received on all hospital visits. Doctors also noted hyperactive bowel sounds More
โœ“
2828940 59 F MN 03/01/2025 PNC21
 MERCK & CO. INC.
 y013009
Erythema, Injection site swelling, Pain in extremity, Pruritus Erythema, Injection site swelling, Pain in extremity, Pruritus
Patient states that since the evening of injection she has developed a red red 1/2 the width of her ... Patient states that since the evening of injection she has developed a red red 1/2 the width of her arm. It is painful and has bouts of itching. The skin is swollen she states and has been advancing from injection site to elbow More
2828941 74 M MA 03/01/2025 COVID19
COVID19
 MODERNA
MODERNA

Brain oedema, Cerebral haemorrhage, Concussion, Dizziness, Head injury; Syncope Brain oedema, Cerebral haemorrhage, Concussion, Dizziness, Head injury; Syncope
Less than 24 hours after vaccination, the patient experienced extreme dizziness and collapsed. He hi... Less than 24 hours after vaccination, the patient experienced extreme dizziness and collapsed. He hit his head, causing a concussion, brain swelling, and bleeding in the brain. The patient was rushed to Hospital emergency room and transferred to Hospital trauma unit. More
โœ“
2828942 50 F AZ 03/01/2025 COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 EJ1685
EL1283
FF2587
Skin cancer; Skin cancer; Skin cancer Skin cancer; Skin cancer; Skin cancer
Skin cancer on left side of face 8/21 and skin cancer left shoulder in 2021 as well Skin cancer on left side of face 8/21 and skin cancer left shoulder in 2021 as well
2828943 68 M TX 03/01/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 93kk4
Fall, Injury, Limb injury, Loss of consciousness Fall, Injury, Limb injury, Loss of consciousness
Patient states he fell on boat the next day and he passed out once he got home. Patient states fall... Patient states he fell on boat the next day and he passed out once he got home. Patient states fall and passing out resulted in minor injuries and a hurt toe. More
2828945 40 F OR 03/01/2025 COVID19
 PFIZER\BIONTECH
Dyspnoea, Echocardiogram, Tachycardia Dyspnoea, Echocardiogram, Tachycardia
Tachycardia Heart rate 140-160 24hrs a day x 2 years, shortness of breathe x 2 years Tachycardia Heart rate 140-160 24hrs a day x 2 years, shortness of breathe x 2 years
2829024 M FL 03/01/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 L5229
Extra dose administered, No adverse event Extra dose administered, No adverse event
No adverse event. Duplicate dose. 1st given 7/24 & 2nd 2/25 No adverse event. Duplicate dose. 1st given 7/24 & 2nd 2/25
2828711 M NM 02/28/2025 HEP
 MERCK & CO. INC.
 Y006509
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
A HCP called to inquire about how to administer a second dose of RECCOMBIVAX HB that would be late a... A HCP called to inquire about how to administer a second dose of RECCOMBIVAX HB that would be late according to the recommended schedule. The HCP stated a 32 year old patient received their first dose of RECOMBIVAX HB on 08/26/2024 and he was antici; No additional adverse event; This spontaneous report has been received from a nurse regarding a 32-year-old male patient. The patient's pertinent medical history, current conditions, concomitant medications, previous drug reactions or allergies were not reported. On 26-AUG-2024, the patient was vaccinated with the first dose of hepatitis b vaccine (recombinant) suspension for injection (RECOMBIVAX HB), administered as prophylaxis 1 mL (Lot No. Y006509 has been verified to be a valid lot number for [hepatitis b vaccine (recombinant) suspension for injection], expiration date reported and upon internal validation established as 11-FEB-2027 (strength, route and anatomical location of administration and vaccination scheme frequency were not provided). It was stated that the nurse called to inquire about how to administer a second dose of the vaccine that would be late according to the recommended schedule as the patient supposed to come to the clinic to receive his second dose of the vaccine on 26-FEB-2025 (inappropriate schedule of product administration). No additional adverse event (AE) (no adverse event) was reported. More
2828712 GA 02/28/2025 DTAPHEPBIP
HEP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 UNK
UNK
Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
pediatric patient received Pediarix and Engerix-B the same day; This non-serious case was reported b... pediatric patient received Pediarix and Engerix-B the same day; This non-serious case was reported by a other health professional via call center representative and described the occurrence of overdose in a patient who received HBV (Engerix B) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. Previously administered products included Pediarix (received on 24-SEP-2024). On 03-FEB-2025, the patient received Engerix B and Pediarix. On 03-FEB-2025, an unknown time after receiving Engerix B and Pediarix, the patient experienced overdose (Verbatim: pediatric patient received Pediarix and Engerix-B the same day). The outcome of the overdose was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-FEB-2025. Practice Manager and explained that they administered an extra dose of Hepatitis B vaccine, since a pediatric patient received Pediarix and Engerix-B the same day which led to overdose. Caller mentioned that patient received a prior Pediarix dose and no prior Engerix-B doses. Lot number and expiration date for the vaccines were not asked by the agent, but practice manager gave consent to follow up with safety if additional information was needed. More
2828713 45 F FL 02/28/2025 COVID19-2
 MODERNA
 unknown
Guillain-Barre syndrome, Investigation Guillain-Barre syndrome, Investigation
I had Guillain Barr๏ฟฝ with a very heavy paralysis; This spontaneous case was reported by a patient ... I had Guillain Barr๏ฟฝ with a very heavy paralysis; This spontaneous case was reported by a patient and describes the occurrence of GUILLAIN-BARRE SYNDROME (I had Guillain Barr๏ฟฝ with a very heavy paralysis) in a 46-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. unknown) for COVID-19 prophylaxis. Concomitant products included Immunoglobulins and Steroids for an unknown indication. On 07-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular use) 1 milliliter. On 22-Dec-2022, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced GUILLAIN-BARRE SYNDROME (I had Guillain Barr๏ฟฝ with a very heavy paralysis) (seriousness criterion medically significant). The patient was treated with Rehabilitation therapy for Guillain-Barre syndrome. On 08-Jan-2023, GUILLAIN-BARRE SYNDROME (I had Guillain Barr๏ฟฝ with a very heavy paralysis) had resolved with sequelae. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Investigation: after many tests and differentiated diagnostics, I had Guillain Barr๏ฟฝ with a very heavy paralysis. The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular use) was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular use), the reporter did not provide any causality assessments. No concomitant medications were reported. After many tests and differentiated diagnostics, the patient had Guillain barre with a very heavy paralysis. The patient had full mobility now, after 2 years in physical rehab and therapies, the patient battles their consequences and sinkinesis in her face. No treatment medications were reported.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report. More
2828723 02/28/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure
suspected vaccination failure; shingles; This serious case was reported by a consumer via interactiv... suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 21-FEB-2025 This case was reported by a patient via interactive digital media. Patient had vaccine and got shingles twice last year. Still shingles with him/her 4 months later. The patient further said it would be good if it worked. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine. More
2828724 IL 02/28/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 DD72H
Extra dose administered, Product label confusion Extra dose administered, Product label confusion
Product Confusion; This non-serious case was reported by a nurse via call center representative and ... Product Confusion; This non-serious case was reported by a nurse via call center representative and described the occurrence of product label confusion in a patient who received Men B NVS (Bexsero) (batch number DD72H, expiry date 30-NOV-2027) for prophylaxis. On an unknown date, the patient received the 3rd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced product label confusion (Verbatim: Product Confusion). The outcome of the product label confusion was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-FEB-2025 The reporter was a nurse from a pediatric office. She reports that they administer Bexsero vaccine. Inappropriate schedule of vaccine, the nurse states they order Bexsero and have been giving it at day one and one month later (as according to the old schedule) due to this an unknown number of patients would now have to receive a third dose. The office staff were unaware of the dosing schedule change because they did not receive a notification. If they had known, they could have advised the patients not to return until the 6 month mark. The nurse was confused as to why the paper copy package insert inside the Bexsero vaccine box (which expires in 2027) would still be showing the original dosing schedule, which led to product label confusion. The vaccine administration facility was the same as primary reporter. More
2828725 M PA 02/28/2025 RSV
RSV
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Central sleep apnoea syndrome, Foetal exposure during pregnancy, Hypotonia, Leth... Central sleep apnoea syndrome, Foetal exposure during pregnancy, Hypotonia, Lethargy, Obstructive sleep apnoea syndrome; Respiratory syncytial virus infection, Tachycardia, Tachypnoea More
obstuctive sleep apnea; central sleep apnea; tachycardia; tachypnea; hypotonia; RSV; This serious re... obstuctive sleep apnea; central sleep apnea; tachycardia; tachypnea; hypotonia; RSV; This serious retrospective pregnancy case was reported by a other health professional via call center representative and described the occurrence of obstructive sleep apnea in a male infant exposed to RSVPreF3 adjuvanted (Arexvy) in utero. The mother received the product for prophylaxis. On an unknown date, the 33-year-old mother received Arexvy. The infant was diagnosed with obstructive sleep apnea (Verbatim: obstuctive sleep apnea) (serious criteria hospitalization), central sleep apnea syndrome (Verbatim: central sleep apnea) (serious criteria hospitalization and GSK medically significant), tachycardia (Verbatim: tachycardia) (serious criteria hospitalization), tachypnea (Verbatim: tachypnea) (serious criteria hospitalization), hypotonia (Verbatim: hypotonia) (serious criteria hospitalization) and respiratory syncytial virus infection (Verbatim: RSV) (serious criteria hospitalization). The outcome of the obstructive sleep apnea, central sleep apnea syndrome, tachycardia, tachypnea and hypotonia were not resolved and the outcome of the respiratory syncytial virus infection was unknown. It was unknown if the reporter considered the obstructive sleep apnea, central sleep apnea syndrome, tachycardia, tachypnea, hypotonia and respiratory syncytial virus infection to be related to Arexvy. The company considered the obstructive sleep apnea, central sleep apnea syndrome, tachycardia, tachypnea, hypotonia and respiratory syncytial virus infection to be unrelated to Arexvy. Pregnancy Details (Neonate 1): Actual Delivery Date: Pregnancy Outcome: Live neonate with no apparent congenital anomaly Delivery Notes: She delivered at 37 weeks and 1 day See case US2025021327 for details regarding the mother case. Additional Information: GSK Receipt Date: 19-FEB-2025 The health care professional reported that a patient's mother received Arexvy at 33 weeks gestation and the child was have having sleep apnea (central and obstructive) which began shortly after coming home from the hospital and also experienced tachycardia, tachypnea, and hypotonia. This all began after one week of being home and has been hospitalized a couple times since. Patient was seen as and outpatient today for a second opinion. The child was still continuing to experience symptoms. The child was on oxygen. The child also developed respiratory syncytial virus infection twice and was hospitalized for it. The first date of occurrence for respiratory syncytial virus infection was unknown as there are no details available but the child was hospitalized a second time for respiratory syncytial virus infection on 28-Jan-2025 respiratory syncytial virus infection for 5 days. The child also had an adverse reaction to his 2 month vaccines a very lethargic response that lasted for several days afterwards. The health care professional was unsure which vaccines the child received at his 2 month visit. No details regarding lot or expiration date of Arexvy is available or date which patient received Arexvy.; Sender's Comments: Obstructive sleep apnoea syndrome, Central sleep apnoea syndrome, Tachycardia, Tachypnoea, Hypotonia and Respiratory syncytial virus infection are unlisted event which is considered unrelated to GSK vaccine Arexvy. US-GSK-US2025021327:Mother case More
โœ“
2828726 55 M CA 02/28/2025 DTAPHEPBIP
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR

Dyspnoea, Heart rate increased, Nausea, Pain, Pyrexia; Dyspnoea, Heart rate incr... Dyspnoea, Heart rate increased, Nausea, Pain, Pyrexia; Dyspnoea, Heart rate increased, Nausea, Pain, Pyrexia More
Fever pain in body nausea fast heart rate can?t breathe Fever pain in body nausea fast heart rate can?t breathe
โœ“
2828736 76 F NC 02/28/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 ER5ZB
Herpes zoster Herpes zoster
Despite prior vaccine, had quite severe case of shingles from 10/2023 - 1/2024 Despite prior vaccine, had quite severe case of shingles from 10/2023 - 1/2024
2828737 1.25 F NC 02/28/2025 DTAP
HIBV
 SANOFI PASTEUR
MERCK & CO. INC.
 2CA77C1
Y003146
Injection site erythema, Injection site warmth, Lymphocyte percentage, Neutrophi... Injection site erythema, Injection site warmth, Lymphocyte percentage, Neutrophil percentage, White blood cell count increased; Injection site erythema, Injection site warmth, Lymphocyte percentage, Neutrophil percentage, White blood cell count increased More
Pt w/onset of progressive redness, warmth at injection site of Hib vaccine. Seen in office w/in 24hr... Pt w/onset of progressive redness, warmth at injection site of Hib vaccine. Seen in office w/in 24hr - CBC checked with slight elevation WBC. Placed on Bactrim to cover possible abscess vs. localized site reaction. More
2828738 90 F OR 02/28/2025 COVID19
FLU3
 MODERNA
SEQIRUS, INC.
 8080803
388490
Injection site mass, Injection site pain; Injection site mass, Injection site pa... Injection site mass, Injection site pain; Injection site mass, Injection site pain More
Pain ongoing - from shoulder to elbow in right arm. Lump in (R) deltoid still present. Has tried ice... Pain ongoing - from shoulder to elbow in right arm. Lump in (R) deltoid still present. Has tried ice + heat pads. heat helps. Taking ibuprofen + APAP Scheduled 3/3/25 w/PCP More
2828806 64 F OH 02/28/2025 COVID19
COVID19
 MODERNA
MODERNA
 571480
571480
Arthralgia, C-reactive protein increased, Muscular weakness, Neck pain, Pain in ... Arthralgia, C-reactive protein increased, Muscular weakness, Neck pain, Pain in extremity; Red blood cell sedimentation rate increased, Shoulder girdle pain More
Bilateral shoulder and girdle pain. Hand and neck pain grip weakness Bilateral shoulder and girdle pain. Hand and neck pain grip weakness
2828807 33 M TX 02/28/2025 COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 EL3248
EL3248
EL3248
EL3248
EL3248
Alpha tumour necrosis factor increased, Biopsy skin abnormal, Burning sensation,... Alpha tumour necrosis factor increased, Biopsy skin abnormal, Burning sensation, Chronic fatigue syndrome, Cytokine increased; Dizziness, Exercise tolerance decreased, Fatigue, Headache, Impaired work ability; Interleukin level increased, Malaise, Mobility decreased, Muscle twitching, Muscular weakness; Paraesthesia, Postural orthostatic tachycardia syndrome, Quality of life decreased, Quantitative sudomotor axon reflex test, Tilt table test positive; Tinnitus, Vascular endothelial growth factor assay, Vision blurred, Vitreous floaters More
Burning and tingling of hands and feet, twitching, muscle weakness, headaches, crushing fatigue with... Burning and tingling of hands and feet, twitching, muscle weakness, headaches, crushing fatigue with post-exertional malaise,, myalgic encephalomyelitis, POTS, dizziness, vision changes with blurry vision and floaters, tinnitus. Complete loss of quality of life. Inability to exercise, work, or even get out of bed most days. Damn you Pfizer for lying to us. As a doctor myself, I am stunned at your unethical practices. Shame on you. You have ruined my life. More
โœ“
2828808 11 M FL 02/28/2025 FLU3
FLU3
TDAP
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 495MK
495MK
42G27
42G27
Dizziness, Erythema, Feeling hot, Headache, Pruritus; Pyrexia, Swelling, Urticar... Dizziness, Erythema, Feeling hot, Headache, Pruritus; Pyrexia, Swelling, Urticaria; Dizziness, Erythema, Feeling hot, Headache, Pruritus; Pyrexia, Swelling, Urticaria More
Child had fever, swolle, hives , headaches , dizziness, redness , hot to touch and itchy. Child had fever, swolle, hives , headaches , dizziness, redness , hot to touch and itchy.
2828809 15 M WI 02/28/2025 COVID19
 MODERNA
 B0005
Expired product administered Expired product administered
Patient received a post beyond use date vaccine. Patient received a post beyond use date vaccine.
2828810 72 M FL 02/28/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 4723s
Asthenia, Brain fog, Loss of consciousness, Nervous system disorder Asthenia, Brain fog, Loss of consciousness, Nervous system disorder
Per the patient the following day, after receiving the shingles vaccines, he passed out in the bathr... Per the patient the following day, after receiving the shingles vaccines, he passed out in the bathroom while brushing his teeth. He also felt weak for about 10days and has had a 'foggy' brain and his nerves are affected in his body. More
2828811 10 M FL 02/28/2025 FLU3
HPV9
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 495MK
YOO8640
Unevaluable event; Unevaluable event Unevaluable event; Unevaluable event
N/A N/A
2828812 86 F OH 02/28/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 AE435
Immediate post-injection reaction, Injected limb mobility decreased, Pain in ext... Immediate post-injection reaction, Injected limb mobility decreased, Pain in extremity More
Patient states that she had immediate pain after the injection. She states that the pain continued t... Patient states that she had immediate pain after the injection. She states that the pain continued to get worse in the shoulder and going all the way down the arm. She has since had difficulty lifting her arm and also reaching out with the arm. She has not followed up with a physician at this time. More
2828813 76 F AR 02/28/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 YZ9CY
Diarrhoea, Flushing, Headache, Pyrexia, Rash Diarrhoea, Flushing, Headache, Pyrexia, Rash
Diarrhea, headache, fever, flushing in arm started within 24 hours of vaccine. Rash on arm started y... Diarrhea, headache, fever, flushing in arm started within 24 hours of vaccine. Rash on arm started yesterday. More
2828814 57 F MI 02/28/2025 COVID19
FLU3
 NOVAVAX
SEQIRUS, INC.

Alopecia, Pruritus, Rash; Alopecia, Pruritus, Rash Alopecia, Pruritus, Rash; Alopecia, Pruritus, Rash
Hair loss starting about one month after vaccination. Started with steroid cream which did not impro... Hair loss starting about one month after vaccination. Started with steroid cream which did not improve hair loss. Itching/rash on hands and arms began in December 2024. used same steroid cream to treat which seems to have cleared hands and arms but not hair loss, hair loss getting progressively worse. December referred to dermatologist. Dermatologist did intramuscular steroid shots and prescribed a steroidal foam to use on scalp. That seemed to slow hair loss. Still losing hair but not at the fast pace. More
2828815 74 F 02/28/2025 MNQ
 SANOFI PASTEUR
Injection site reaction Injection site reaction
Patient was administered the MenQuadfi booster on 2/27 and experienced a reaction 14 mins after admi... Patient was administered the MenQuadfi booster on 2/27 and experienced a reaction 14 mins after administration at injection site More
2828816 6 F PA 02/28/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 5G23D
Y016874
Erythema, Peripheral swelling; Erythema, Peripheral swelling Erythema, Peripheral swelling; Erythema, Peripheral swelling
swelling and redness of right upper arm swelling and redness of right upper arm
2828817 0.67 M MN 02/28/2025 HIBV
PNC20
 MERCK & CO. INC.
PFIZER\WYETH
 Y006392
Lx2497
Skin mass; Skin mass Skin mass; Skin mass
~2cm subcutaneous nodule occurred within 72 hours. Slightly improved in the next 48 hours. Patient... ~2cm subcutaneous nodule occurred within 72 hours. Slightly improved in the next 48 hours. Patient well otherwise. More
๐Ÿ“‹ Privacy Policy & Data Disclaimer